Back to top
more

Butterfly Network (BFLY)

(Delayed Data from NYSE)

$1.43 USD

1.43
3,560,714

+0.03 (2.14%)

Updated Aug 4, 2025 04:00 PM ET

After-Market: $1.42 -0.01 (-0.70%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (63 out of 246)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research

Butterfly Network (BFLY) delivered earnings and revenue surprises of +14.29% and -2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Tempus AI vs. Butterfly: Which AI Health Tech Stock is the Better Buy?

by Urmimala Biswas

BFLY outpaces TEM with stronger upside, leaner valuation, and expanding global reach in AI-powered diagnostics.

Zacks Equity Research

Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Butterfly Network (BFLY) delivered earnings and revenue surprises of 33.33% and 1.58%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights Veeva Systems, Hims & Hers Health and Butterfly Network

by Zacks Equity Research

Veeva Systems, Hims & Hers Health and Butterfly Network are part of the Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era

by Urmimala Biswas

Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.

Urmimala Biswas headshot

Beyond Tempus AI: 2 Health IT Stocks Poised for Growth in 2025

by Urmimala Biswas

AI-driven healthcare companies like Butterfly Network and Health Catalyst have all the qualities to emerge as the next big players.

Zacks Equity Research

Down -34.51% in 4 Weeks, Here's Why You Should You Buy the Dip in Butterfly Network (BFLY)

by Zacks Equity Research

Butterfly Network (BFLY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks Equity Research

Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Butterfly Network (BFLY) delivered earnings and revenue surprises of 20% and 0.18%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Hims & Hers Health, Inc. (HIMS) Lags Q4 Earnings Estimates

by Zacks Equity Research

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -8.33% and 2.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Butterfly Network, Inc. (BFLY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Butterfly Network (BFLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

Zacks Equity Research

Is Butterfly Network (BFLY) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Butterfly Network, Inc. (BFLY) and argenex SE (ARGX) have performed compared to their sector so far this year.

Zacks Equity Research

The Zacks Analyst Blog Highlights Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health

by Zacks Equity Research

Inspire Medical, Omnicell, Talkspace, Butterfly Network and Clover Health are included in this Analyst Blog.

Nalak Das headshot

5 Medical Info System Stocks to Buy for a Stable Portfolio in 2025

by Nalak Das

Five medical info systems stocks have strong potential for 2025. These are: INSP, OMCL, TALK, BFLY, CLOV.

Zacks Equity Research

Is Atea Pharmaceuticals (AVIR) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Atea Pharmaceuticals, Inc. (AVIR) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

Zacks Equity Research

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

by Zacks Equity Research

Here is how Bausch Health (BHC) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

Zacks Equity Research

Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Butterfly Network (BFLY) delivered earnings and revenue surprises of 20% and 7.54%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod

by Zacks Equity Research

GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.

Zacks Equity Research

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.

Zacks Equity Research

Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Butterfly Network, Inc. (BFLY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Zacks Equity Research

Butterfly Network's Stock Surges on iQ3 Device Launch in Europe

by Zacks Equity Research

Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.

Zacks Equity Research

Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Butterfly Network (BFLY) delivered earnings and revenue surprises of 50% and 7.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -420% and 3.29%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

by Zacks Equity Research

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

Nalak Das headshot

5 Medical Info Systems Stocks to Buy for Stable Returns

by Nalak Das

We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.